Skip to main content

Advertisement

Log in

Epidemiologic analysis of glycopeptide-resistantEnterococcus strains in neutropenic patients receiving prolonged vancomycin administration

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Vancomycin-resistant enterococci have been isolated with increasing frequency since 1988. Thus far, most of these resistant enterococci have belonged to theEnterococcus faecium species, and epidemiological studies have shown a wide diversity among inter-hospital and intrahospital isolates. This report presents an epidemiologic investigation of 25 vancomycin-resistantEnterococcus strains — 24Enterococcus faecium and oneEnterococcus gallinarum — isolated from the stools or blood of adult patients receiving intravenous vancomycin prophylaxis during neutropenia and hospitalized in a single hematologic unit. Macrorestriction patterns of total DNA and of ribosomal DNA regions were used to analyze the strains. Strains produced different total DNA restriction fragment length polymorphism patterns after Smal digestion. Ribotyping was less discriminative than pulsed-field gel electrophoresis. The results confirmed the genetic unrelatedness of the strains. Prolonged vancomycin administration, commonly used in hematologic units, could be involved in the selection of endogenous resistant enterococcal strains.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Kaplan AH, Gilligan PH, Facklam RR: Recovery of resistant enterococci during vancomycin prophylaxis. Journal of Clinical Microbiology 1988, 26: 1216–1218.

    PubMed  Google Scholar 

  2. Dutka-Malen S, Blaimont B, Wauters G, Courvalin P: Emergence of high-level resistance to glycopeptides inEnterococcus gallinarum andEnterococcus casseliflavus. Antimicrobial Agents and Chemotherapy 1994, 38: 1675–1677.

    PubMed  Google Scholar 

  3. Dutka-Malen S, Leclercq R, Coutant V, Duval J, Courvalin P: Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria. Antimicrobial Agents and Chemotherapy 1990, 34: 1875–1879.

    PubMed  Google Scholar 

  4. Arthur M, Molinas C, Depardieu F, Courvalin P: Characterization ofTn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors inEnterococcus faecium BM4147. Journal of Bacteriology 1993, 175: 117–127.

    PubMed  Google Scholar 

  5. Gold HS, Unal S, Cercenado E, Thauvin-Eliopoulos C, Eliopoulos GM, Wennersten CB, Moellering RC: A gene conferring resistance to vancomycin but not teicoplanin in isolates ofEnterococcus faecalis andEnterococcus faecium demonstrates homology withvanB, vanA andvanC genes of enterococci. Antimicrobial Agents and Chemotherapy 1993, 37: 1604–1609.

    PubMed  Google Scholar 

  6. Leclercq R, Dutka-Malen S, Duval J, Courvalin P: Vancomycin resistance genevanC is specific toEnterococcus gallinarum. Antimicrobial Agents and Chemotherapy 1992, 36: 2005–2008.

    PubMed  Google Scholar 

  7. Boom R, Sol CJA, Salimans MMM, Jansen CL, Wertheim-Van Dillen PME, Van Der Noorda J: Rapid and simple method for purification of nucleic acids. Journal of Clinical Microbiology 1990, 28: 495–503.

    PubMed  Google Scholar 

  8. Clark NC, Cooksey RC, Hill BC, Swenson JM, Tenover FC: Characterization of glycopeptide-resistant enterococci from US hospitals. Antimicrobial Agents and Chemotherapy 1993, 37: 2311–2317.

    PubMed  Google Scholar 

  9. Griffais R, André PM, Thibon M: K-tuple frequency in the human genome and polymerase chain reaction. Nucleic Acids Research 1991, 19: 3887–3891.

    PubMed  Google Scholar 

  10. Bétrémieux P, Donnio PY, Pladys P: Use of ribotyping to investigate trachéal colonisation byStaphylococcus epidermidis as a source of bacteremia in ventilated newborns. European Journal of Clinical Microbiology & Infectious Diseases 1995, 14: 342–346.

    Google Scholar 

  11. Wilson KH, Blitchington RB, Greene RC: Amplification of bacterial 16S ribosomal DNA with polymerase chain reaction. Journal of Clinical Microbiology 1990, 28:1942–1946.

    PubMed  Google Scholar 

  12. Griffais R, André PM, Thibon M: Synthesis of digoxigenin-labelled DNA probe to polymerase chain reaction: application to Epstein-Barr virus andChlamydia trachomatis. Research in Virology 1990, 141: 331–335.

    PubMed  Google Scholar 

  13. Branger B, Bouziges N, Houles R: Epidémie d'infection à streptocoques du groupe G dans une unité d'hémodialyse. Néphrologie 1991, 12: 227–232.

    Google Scholar 

  14. Lamy T, Michelet C, Dauriac C, Donnio PY, Le Prisé PY: Benefit of prophylaxis by intravenous systemic vancomycin in granulocytopenic patients: a prospective, randomized trial among 59 patients. Acta Haematologia 1993, 90: 109–113.

    Google Scholar 

  15. Attal M, Schlaifer D, Rubie H, Huguet F, Charlet JP, Bloom E, Lemozy J, Massip P, Pris J, Laurent G: Prevention of gram-positive infections after bone marrow transplantation by systemic vancomycin: a prospective, randomized trial. Journal of Clinical Oncology 1991, 5: 865–870.

    Google Scholar 

  16. Leclerq R, Derlot E, Duval J, Courvalin P: Plasmid-mediated resistance to vancomycin and teicoplanin inEnterococcus faecium. New England Journal of Medicine 1988, 319: 157–161.

    PubMed  Google Scholar 

  17. Uttley AHC, George RC, Naidoo J, Woodford N, Johnson AP, Collins CH, Morrison D, Gilfillan AF, Fitch LE, Heptonstall J: High-level vancomycin-resistant enterococci causing hospital infections. Epidemiology and Infection 1989, 103: 173–181.

    PubMed  Google Scholar 

  18. Sader HS, Pfaller MA, Tenover FC, Hollis RJ, Jones RN: Evaluation and characterization of multiresistantEnterococcus faecium from 12 US medical centers. Journal of Clinical Microbiology 1994, 32: 2840–2842.

    PubMed  Google Scholar 

  19. Woodford N, Morrisson D, Johnson AP, Briant V, George RC, Cookson B: Application of DNA probes for rRNA andvanA genes to investigation of a nosocomial cluster of vancomycin-resistant enterococci. Journal of Clinical Microbiology 1993, 31: 653–658.

    PubMed  Google Scholar 

  20. Bingen EH, Denamur E, Lambert-Zechovsky N, Elion J: Evidence for the genetic unrelatedness of nosocomial vancomycin-resistant strains in a pediatric hospital. Anti-microbial Agents and Chemotherapy 1991, 29: 1888–1892.

    Google Scholar 

  21. Leclerq R: Epidémiologie de la résistance aux glycopeptides. In: Couland JP, Pocidalo JJ, Régnier B, Vachon F, Vildé JL (ed): Infection nosocomiale et résistance aux antibiotiques: évolution et tendances. Journées de l'Hospital Claude-Bernard. Arnette, Paris, 1993, p. 79–87.

    Google Scholar 

  22. Auge B, Donnio PY, Le Déaut P, Avril JL: Influence de la vancomycine par voie veineuse sur les flores aérobies salivaires et fécales. Pathologie Biologie 1987, 35: 673–675.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Plessis, P., Lamy, T., Donnio, P.Y. et al. Epidemiologic analysis of glycopeptide-resistantEnterococcus strains in neutropenic patients receiving prolonged vancomycin administration. Eur. J. Clin. Microbiol. Infect. Dis. 14, 959–963 (1995). https://doi.org/10.1007/BF01691377

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01691377

Keywords

Navigation